Probiotic efficacy is based not on gross numbers or vague species classification, but on specific bacterial strains characterized by demonstrated functional properties, viability, and host microbiome suitability. This paper challenges the overly simplistic industry standard that focuses on colony-forming unit content and species classification, demanding a science-driven model founded on strain-level specificity instead. We establish important criteria—acid and bile resistance, proteolytic activity, immunomodulation, and microbial compatibility—that can forecast whether a probiotic will endure gastrointestinal transit and deliver health-supporting properties. Strain-specific traits, founded on genomic and metabolomic description, are essential to distinguishing from functional probiotics those that are inactive or even harmful. Adaptive laboratory evolution offers a platform for strain improvement by natural evolution as opposed to genetic modification, optimizing performance while guaranteeing non-GMO status. Such advances are supplemented by consideration of the ecology of the microbiome, where incorporation into the host is an inherent determinant of long-term probiotic success. We highlight the importance of transparency regarding strain identity. As a case in point, we present a patented Lactobacillus plantarum strain developed through adaptive laboratory evolution—that exemplifies modern probiotic development through demonstrated lab-based resilience, host compatibility, and functional optimization. Ultimately, the future of probiotics is not one of mass, but of specificity. Products developed on rigorous scientific principles will establish a new benchmark of safety and dependability that will make probiotics more than broad supplements but rather precision tools for gut and immunity function.